Avillion/AstraZeneca’s Budesonide/Albuterol Combo For Asthma Has ‘Uncertain’ Pediatric Benefit

 
• By Sue Sutter
  
Foot bridge
FDA asks whether extrapolation of adult data is appropriate as a bridge to efficacy in the pediatric population. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers